Back to Stakeholders
Funding & InvestmentFoundations & PhilanthropyGrant-Making Organizations
Funding & InvestmentFoundations & Philanthropy
Funding & Investment
Government, Policy & AdvocacyPublic Sector Health & Drug Governance
Government, Policy & Advocacy
Government, Policy & AdvocacyPublic Sector Health & Drug GovernanceNational Ministries & Federal Agencies

Health Research Board, Ireland

Ireland
1 Trial

The Health Research Board (HRB) is Ireland's primary statutory health research funding agency, which has awarded grants to Trinity College Dublin's Psychedelic Research Group to investigate psychedelics' immune effects in depression and the feasibility of psilocybin for cocaine-use disorder. The HRB also funds the KARMA-DEP(2) ketamine trial for treatment-resistant depression at St Patrick's University Hospital in Dublin, making it a key enabler of Ireland's emerging psychedelic medicine ecosystem.

Foundations & Philanthropy Snapshot

Grant-Making Organizations

Classification

Public Charity / Non-Profit

Geography

Global

Coverage

Global

Last Verified

Apr 10, 2026

Funding Focus Areas

Academic Research Funding

Support Types

Grant Funding

Philanthropy Notes

Auto-backfilled baseline philanthropy profile from existing category tags and website. Manual enrichment recommended for recipient-level details.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Verification Notes

Verified against official HRB funding pages.

Primary Funding Link

Source Evidence

Health Research Board, Ireland website

https://www.hrb.ie

HRB Ireland Home

https://www.hrb.ie

HRB Funding Schemes

https://www.hrb.ie/funding/

Quick Facts

Type
Other
HQ
Ireland
Website
Visit

Collaborated Trials

1
CompletedI

Ketamine for Depression Relapse Prevention Following ECT

Start Date
Compounds
Ketamine, Placebo